Ticker: STOK

Company: Stoke Therapeutics, Inc.

Person: Kaye Edward M MD, director

Transaction date: Dec. 3, 2025

Reporting date: Dec. 5, 2025

Average share price: -41.51114881322784

Sold 11249.0 shares for 466958.91